Mountain View, CA, United States of America

Kai Cheng

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Cheng. Retrieved from https://idiyas.com/inventor/kai-cheng-b4mrsy6o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Mountain View, CA (US) (2018 - 2021)
  • Lexington, KY (US) (2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Inventor Kai Cheng

Introduction

Kai Cheng is an accomplished inventor based in Mountain View, California. He has made significant contributions to the field of imaging systems and molecular therapy, holding a total of three patents. His work is characterized by innovative approaches to complex problems in technology and medicine.

Latest Patents

One of his latest patents is the "Folded parallel-light-channel based stereo imaging system." This stereo imaging system includes a pair of folded-parallel-light-channel (FPLC) units that provide virtual left and right side views of a scene. Each FPLC unit is designed with a fixed lens unit that focuses reflected light to an image sensor, along with a light-redirecting unit that defines a parallel image reflection path via a collimated light beam.

Another notable patent is the "Small molecule dye for molecular imaging and photothermal therapy." This invention involves a small molecule dye that operates in the near-infrared window, specifically between 1000 nm and 1700 nm wavelengths. The dyes are useful for photoacoustic imaging and photothermal therapy, featuring a D-A-D (donor-acceptor-donor) fluorescent compound core with water-soluble side chains. The compound CH1055 can be PEGylated or conjugated to targeting ligands, enhancing its applicability in medical imaging and treatment.

Career Highlights

Kai Cheng is currently affiliated with Leland Stanford Junior University, where he continues to push the boundaries of research and innovation. His work has garnered attention for its potential applications in both technology and healthcare.

Collaborations

Some of his notable coworkers include Zhen Cheng and Xuechuan Hong, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Kai Cheng's contributions to the fields of imaging systems and molecular therapy highlight his role as a leading inventor. His innovative patents reflect a commitment to advancing technology and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…